Vivo Bio Tech share news, announcements and annual reports
NSE: VIVOBIOTBSE: 511509Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹13.87.
29 Oct: open ₹13.58, high ₹14.09, low ₹13.49
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹31 Cr3,302nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.33
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.60 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −2.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.72
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,84371.4% delivered
Vivo Bio Tech share news and announcements
594 announcements, routine notices left out, newest first. Page 7 of 12.
Mar 2021
31 Mar · Announcement under Regulation 30 (LODR)-Allotment
31 Mar · Board meeting
26 Mar · Announcement under Regulation 30 (LODR)-Allotment
Feb 2021
1 Feb · Board meeting
Meeting on 10 Feb 2021: quarterly results
Jan 2021
18 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....12 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2020
10 Dec · Regulation 23(9)-Disclosure Of Related Party Transactions On Consolidated Basis For The Half Year Ended On 30Th September, 2020
Nov 2020
26 Nov · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on November 26, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....23 Nov · Shareholding for the Period Ended November 21, 2020
Shareholding Pattern for the Period Ended November 21, 2020. For more details, kindly Click ....12 Nov · Announcement under Regulation 30 (LODR)-Allotment
2 Nov · Board meeting
Meeting on 11 Nov 2020: quarterly results
Oct 2020
19 Oct · Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations,2015
15 Oct · Reg 7(3)-Compliance Certificate For The Half Year Ended 30Th September, 2020
15 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....15 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Oct · Report On Inadvertent Trading By Designated Persons.
Sep 2020
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....28 Sep · Meeting
5 Sep · Reg. 34 (1) Annual Report
Aug 2020
28 Aug · Closure Of Register Of Members And Transfer Books Of The Company.
20 Aug · Legal
20 Aug · Legal
Exchange has sought clarification from Vivo Bio Tech Ltd on August 20, 2020, with reference to Movement in Price. The reply is awaited.19 Aug · Board meeting
Meeting on 28 Aug 2020: quarterly results and issue of warrants
Jul 2020
29 Jul · Regulation 23(9)-Disclosure Of Related Party Transactions On Consolidated Basis For The Year Ended On 31St March, 2020
21 Jul · Declaration Under Regulation 33 (3) (D) Of The SEBI (LODR) Regulations, 2015.
18 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....